# Effect of Meditation and Controls and Subjects With Parkinson's Disease on Brain Activity Measured by fMRI With FDOPA

> **NCT05103618** · PHASE2 · WITHDRAWN · sponsor: **Andrew Newberg**

## Conditions studied

- Parkinson Disease
- Idiopathic Parkinson Disease

## Interventions

- **DRUG:** [F-18] Fluorodopa Positron Emission Tomography
- **BEHAVIORAL:** OM Meditation

## Key facts

- **NCT ID:** NCT05103618
- **Lead sponsor:** Andrew Newberg
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-07-08
- **Primary completion:** 2025-07-21
- **Final completion:** 2025-07-21
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** funding not obtained
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05103618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05103618, "Effect of Meditation and Controls and Subjects With Parkinson's Disease on Brain Activity Measured by fMRI With FDOPA". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05103618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*